EMA Authorised: Bildyos (denosumab) — Sciencepharma Sp. z o.o

View source ↗

Summary

EMA authorised Bildyos, a denosumab medicine by Sciencepharma Sp. z o.o., for osteoporosis and postmenopausal osteoporosis related to bone resorption.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Bildyos (denosumab)

Snippet

Status: Authorised. Therapeutic area: Bone Resorption;Osteoporosis, Postmenopausal;Osteoporosis. MAH: Sciencepharma Sp. z o.o. Decision date: 15/01/2026